Login / Signup

Double-bright (CD56bright/CD16bright) natural killer cell adoptive immunotherapy for SARS-CoV-2.

Lúcia Silla
Published in: British journal of haematology (2020)
Keyphrases
  • sars cov
  • cell therapy
  • nk cells
  • single cell
  • light emitting
  • stem cells
  • bone marrow